Poor drug distribution as a possible explanation for the results of the PRECISE trial

John H. Sampson, Gary Archer, Christoph Pedain, Eva Wembacher-Schröder, Manfred Westphal, Sandeep Kunwar, Michael A. Vogelbaum, April Coan, James E. Herndon, Raghu Raghavan, Martin L. Brady, Davi D A Reardon, Allan H. Friedman, Henry S. Friedman, M. Inmaculada Rodríguez-Ponce, Susan M. Chang, Stephan Mittermeyer, Davi Croteau, Raj K. Puri, James Mac Dowell MarkertMichael Prados, Thomas Chen, Adam Mamelak, Timothy Cloughesy, John Yu, Kevin Lillehei, Joseph Piepmeier, Edward Pan, Frank Vrionis, H. Lee Moffitt, Jeffrey Olson, James Chandler, Nina Paleologos, Richard W. Byrne, Maciej Lesniak, Jon D. Weingart, Peter Black, Tom Mikkelsen, Joon Uhm, Richard Bucholz, Lauren Abrey, Theodore H. Schwartz, Jeffrey Bruce, Anthony Asher, Stephen Tatter, Gene Barnett, Antonio E. Chiocca, Johnny B. Delashaw, Kevin Judy, Sunil Patel, Bruce Frankel, Fred Lang, Pamela New, Karen Fink, Randy L. Jensen, Mark Shaffrey, Lynne Taylor, Warren Boling, Behnam Badie, Abhijit Guha, Vivek Mehta, Mark Hamilton, David D. Eisenstat, Farhad Pirouzmand, David Macdonald, Rolando Del Maestro, Daryl Fourney, Maximilian Mehdorn, Roland Goldbrunner, Gabriele Schackert, Andreas Unterberg, Zvi Ram, Zvi Cohen, Zvi Rappaport, Jan Jacob Mooij, John G. Wolbers, Peter Warnke, Varnavas Papanastassiou

Research output: Contribution to journalArticlepeer-review

174 Scopus citations

Fingerprint

Dive into the research topics of 'Poor drug distribution as a possible explanation for the results of the PRECISE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences